MiRNA-based therapy for Life span extension: FOXO3A inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 10/October/2014, 7.29 am

MiRNA-based therapy for Life span extension: FOXO3A inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 10/October/2014, 7.29 am

MiRNA-based therapy for Life span extension: FOXO3A inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 10/October/2014, 7.29 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., MiRNA-based therapy for Life span extension: FOXO3A inhibits senescence and  extends life span by down regulating the expression of  adenylate cyclase 5 (ADCY5), 10/October/2014, 7.29 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that FOXO3A may extend the lifespan of an individual by suppressing ADCY5 expression.   Thus, pharmacological formulations encompassing “FOXO3A or its activators” may be used to extend the lifespan of an an individual.